#IRF8
Review @jimmunology.bsky.social
Transcriptional control of type 1 classical dendritic cell development via Irf8 super-enhancer
academic.oup.com/jimmunol/art...
November 16, 2026 at 6:50 PM
Epigenetics Update - Histone deacetylase inhibition induces an antitumor IRF8-dependent trained immunity-like status in macrophages www.nature.com/articles/s41...

#Epigenetics #HDAC #Immunity #Cancer #IRF8 #Macrophages
---

Discover the breakthrough at epigenometech.com
October 29, 2026 at 7:46 AM
When did these changes happen? Using all seven high-coverage Neandertal and Denisovan genomes, we found that nearly all (99.6%) gains now fixed in humans predate the split from archaic hominins, yet a few modern-human-specific gains (e.g. at IRF8 in liver) substantially upregulate their targets.
October 23, 2026 at 1:11 PM
The transcription factor IRF8 drives tumor-specific exhaustion in CD8⁺ T Cells. From Marco Ongaro, Grégory Verdeil and colleagues: rupress.org/jem/article/...

📘 Part of our #Cytokines collection: rupress.org/jem/collecti...

#Cytokines2026
October 17, 2026 at 8:01 AM
Tang, Sun, Yang, et al. reprogrammed glioma stem cells (GSCs) into cDC1-like cells in situ by administering a hydrogel to the post-op tumor cavity for slow and local delivery of CD133-targeting LNPs carrying plasmids encoding PIB (PU.1, IRF8, BATF3) and costimulatory TNFSF9.
bit.ly/4s53Kly
October 16, 2026 at 3:30 PM
RRIDs were included in this in Genes, Chromosomes and Cancer paper. Thanks for making your methods matter! #OpenResearch #reproducibility #BetterScience
IRF8 Suppresses Hepatocellular Carcinoma Progression Through LIAS‐Dependent IFN Production and Cuproptosis Activation
Read the full paper: IRF8 Suppresses Hepatocellular Carcinoma Progression Through LIAS‐Dependent IFN Production and Cuproptosis Activation
doi.org
October 7, 2026 at 7:01 AM
The IRF8-CCL8-CCR5 axis as an epigenetically potentiated nexus of innate and adaptive antitumor immunity @natcomms.nature.com
www.nature.com/articles/s41...
September 27, 2026 at 7:50 PM
Three sisters Cumbria all diagnosed with 'extremely rare' condition

#Cumbria
Three sisters Cumbria all diagnosed with
Sinead, Caitlyn and Rhiann Heyworth that they have a condition called IRF8 gene deficiency which means they will need 'extremely intensive…
www.newsandstar.co.uk
September 14, 2026 at 5:24 PM
The transcription factor IRF8 drives tumor-specific exhaustion in CD8⁺ T Cells. From Marco Ongaro, Grégory Verdeil and colleagues: rupress.org/jem/article/...

Part of our #CancerImmunotherapy 2026
👉 rupress.org/jem/collecti...
#CSHAsia
September 11, 2026 at 12:01 AM
Após vencer câncer três vezes, mãe solo mãe vê três filhas enfrentarem quimioterapia
Uma mãe solteira que lutou contra o câncer três vezes agora precisa cuidar de três de suas filhas, depois que um diagnóstico triplo brutal exigiu que todas elas fizessem quimioterapia. Lesley Owens, de 43 anos, ficou arrasada ao descobrir recentemente que as meninas com idades entre 16 e 20 anos, foram diagnosticadas com deficiência do gene IRF8, uma condição genética extremamente rara que deixa o sistema imunológico incapaz de combater infecções. Elas agora precisam de quimioterapia intensiva para se prepararem para possíveis transplantes de medula óssea e células-tronco, visando a recuperação. Tragicamente, a filha mais velha, Sinead, de 20 anos, também foi diagnosticada com câncer de vulva. A mais nova, Rhiann, de 16 anos, também apresentou células cancerígenas na mesma área. A filha do meio, Caitlyn, de 18 anos, aguarda os resultados dos exames para determinar se também possui células cancerígenas. Após vencer câncer três vezes, mãe solo mãe vê três filhas enfrentarem quimioterapia Reprodução/Mirror Em uma entrevista exclusiva ao Mirror, Tyler Heyworth, irmã mais velha das três meninas que moram em Horden, Durham, Inglaterra, e que lutam contra doenças desde sempre, falou conosco sobre o diagnóstico devastador. Ela também criou uma campanha no GoFundMe para ajudar a aliviar o fardo financeiro e pagar por perucas, roupas e transporte de ida e volta para o Royal Victoria Infirmary, em Newcastle, onde os entes queridos têm dependido de carros de aplicativo. Tyler, de 25 anos, contou: “Provavelmente foi uma das piores experiências da minha vida. Sou muito próxima das minhas irmãs e, obviamente, todos nós vimos minha mãe passar por isso e o quanto a afetou. Me sinto impotente porque não há nada que eu possa fazer para aliviar a dor, para tirar tudo isso delas.” Tyler, mãe de um menino de 1 ano, acredita que sua família é apenas a segunda no mundo a ser diagnosticada com essa condição ultrarrara, que exige que as irmãs, extremamente vulneráveis ​​a infecções graves, encontrem doadores para transplantes de medula óssea. Segundo relatos, menos de 20 casos de deficiência de IRF8 foram descritos na literatura médica mundial, o que demonstra sua raridade. As corajosas irmãs testemunharam a mãe passar por quimioterapia após sua batalha contra o câncer de pele (carcinoma de células escamosas), que a deixou com a necessidade de uma ostomia — e elas estão se inspirando em sua jornada para superar o momento desafiador. Mas, quanto à parte mais difícil, Tyler disse: “Minha irmã de 16 anos ainda estava na escola quando recebeu o diagnóstico. Ela tinha acabado de completar 16 anos. E, por causa disso, ela teve que perder o baile de formatura. Todos nós temos cabelos longos e bonitos, e esse é um dos nossos traços favoritos. Obviamente, descobrir que vão ter que perder o cabelo... acho que foi isso que mais as chateou.” Mãe Lesley usando peruca Reprodução/Mirror Sinead, Caitlyn e Rhiann Reprodução/Mirror Rhiann já perdeu o cabelo após concluir a quimioterapia e o transplante de medula óssea, mas, depois de receber alta do hospital na semana passada, retornou apenas dois dias depois, após contrair uma infecção no caminho para casa, demonstrando a fragilidade de seu sistema imunológico. Suas irmãs mais velhas agora aguardam o início de seus próprios tratamentos de quimioterapia. Apesar de ser um momento difícil, eles são uma família extremamente unida, e Tyler prestou homenagem à mãe, Lesley, que se tornou um exemplo de força para todos. “Ela tem se levantado e seguido em frente”, disse Tyler. “Obviamente, tendo que ver as filhas passando por isso… e ela também tem meu irmãozinho, Riley, de 13 anos, em casa, que precisa ir para a escola e tudo mais, então a força que ela está demonstrando em meio a tudo isso é incrível, realmente é.” “É realmente inspirador e acho que é isso que deu às meninas a força de que precisavam. Elas viram a mãe passar por isso e a viram superar tudo”, finalizou.
revistacrescer.globo.com
September 11, 2026 at 4:37 AM
T cells by peripheral dendritic cells exacerbates tau-mediated neurodegeneration
cDC1 development depends upon a cDC1-specific super-enhancer +32-kb of the Irf8 gene14. cDC1s are absent in Irf8 +32−/− mice even under pro-inflammatory conditions, without affecting Irf8 function in other leukocytes14,15. We crossed TE4 mice with Irf8 +32−/− mice to generate cDC1-deficient mice on the TE4 background (TE4Δ+32). Four cohorts of mice were generated: E4WT (non-tau, cDC1 sufficient), E4Δ+32 (non-tau, cDC1 deficient), TE4WT (tau expressing, cDC1 sufficient) and TE4Δ+32 (tau expressing, cDC1 deficient; Extended Data Fig. 1a). We assessed cDC1 development in 9.5-month-old TE4 mice, which exhibited robust neuropathology, by sorting common dendritic cell progenitors (CDPs), pre-cDC1 progenitors (pre-DC1s) and pre-cDC2 progenitors (pre-DC2s) from bone marrow and culturing these cells with Flt3L ex vivo for 7 days (Extended Data Fig. 1b,c). CDPs derived from TE4WT mice differentiated into both cDC1s and cDC2s, whereas pre-DC1s and pre-DC2s exclusively generated cDC1s and cDC2s, respectively (Extended Data Fig. 1d). In contrast, TE4Δ+32 CDPs did not generate cDC1s. TE4Δ+32 CDPs still specified into pre-DC1s but failed to mature into cDC1s, whereas cDC2s remained intact (Extended Data Fig. 1d). As a result, cDC1s were absent in tissues including spleen, brain-draining deep cervical lymph nodes (dCLNs), dural meninges and brain parenchymal tissues in TE4Δ+32 mice (Extended Data...
www.nature.com
September 3, 2026 at 10:57 PM
Using Twigstats and IBD we uncover heterogeneity in ancestries and changes in relatedness and mobility patterns during the 1st millennium CE. We also detect selection on variants linked with key immunity genes TLR10-TLR1 and IRF8 in Britain before the medieval period.
April 30, 2026 at 2:30 PM
Using Twigstats and IBD we uncover heterogeneity in ancestries and changes in relatedness and mobility patterns during the 1st millennium CE. We also detect selection on variants linked with key immunity genes TLR10-TLR1 and IRF8 in Britain before the medieval period.
April 30, 2026 at 2:10 PM
"AT-108, a replication-deficient adenoviral vector encoding the human PU.1, IRF8, and BATF3 transcription factors (1), enables in vivo cell-fate conversion of cancer cells and other cells in the tumor microenvironment (TME) into induced cDC1-like cells (iDC1s)"

www.science.org/doi/10.1126/...
Turning tumors against themselves
Cell reprogramming can be used to short-circuit the cancer-immunity cycle
www.science.org
April 3, 2026 at 1:22 AM
IRF8 restrains a neutrophil alarmin program that drives inflammatory remodeling of the bone marrow niche #SingleCell 🧪🧬🖥️
https://www.researchsquare.com/article/rs-9942483/latest
June 26, 2026 at 7:00 AM


IFN-γ Orchestrates Coordinated Immunosuppression in Head and Neck Squamous Cell Carcinoma Through JAK-STAT-IRF8 Signaling: A Transcriptome-Wide Computational Analysis

https://www.biorxiv.org/content/10.64898/2026.03.26.714228v1
March 30, 2026 at 1:08 PM
One of the first in vivo demonstrations that cohesin loss in non-dividing cells can hit hard physiologically, impairing immune function of dendritic cells in mouse. Out in Science Immunology, major contributors: @nickadams-phd.bsky.social, Boris Reizis, Leonid Mirny www.science.org/doi/10.1126/...
Cohesin-mediated chromatin organization controls the differentiation and function of dendritic cells
Chromatin-organizing cohesin complex cooperates with transcription factor IRF8 to enable the functionality of dendritic cells in vivo.
www.science.org
February 9, 2026 at 4:59 PM
Scientists identify the c-Jun–Irf8–CD36 pathway as a key driver of spinal cord scar formation. Targeting CD36 or c-Jun reduced fibrosis and improved motor recovery in mice, pointing to new therapeutic strategies for spinal cord injury. #SpinalCordInjury #Neuroscience
July 2, 2026 at 11:00 AM
6) Meanwhile, miR-124 acts by increasing chromatin accessibility and creating a permissive environment for the reprogramming factors PU.1, IRF8 and BATF3 (PIB) to activate cDC1 programs.
August 13, 2026 at 10:13 AM
2/3 Despite the therapeutic promise of tumor-to-dendritic cell reprogramming by PU.1, IRF8 and BATF3 (PIB) overexpression, reprogramming efficiency is variable across tumors. Sandhya will address this by decoding the nucleosomal structure and temporal dynamics of PIB activity.
April 13, 2026 at 7:27 AM
5) We showed that stoichiometry matters: high PU.1 + high BATF3 + intermediate IRF8 = best cDC1 induction from human fibroblasts or multiple cancer cells.
January 14, 2026 at 4:43 PM
3) By applying multiplexed TF libraries (9, 22, and 42 factors), we reconstructed PIB-mediated (PU.1, IRF8, BATF3) cDC1 reprogramming, enabling resolution of minimal TF combinations and stoichiometries and revealing GATA2 and GFI1B as key enhancers of lineage fidelity.
January 14, 2026 at 4:42 PM
2/2 Exploring the sea of immune cell diversity, our work successfully maps future lanes for dendritic cell reprogramming and cancer immunotherapy!
Illustration by @azuravesta.bsky.social (azuravesta.com)
Read the full paper here: pereiralab.com/publication/...
Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity - Pereira Lab
Highlights Anchored screening identifies ETS-IRF pairs and a third factor specifying DC subsets PU.1, IRF4, and PRDM1 induce a pro-inflammatory cDC2B-like identity SPIB, IRF8, and IKZF2 drive an i...
pereiralab.com
October 14, 2025 at 3:45 PM
5/17 🔀 Both combinations rely on an ETS + IRF pair (PU.1/IRF4 or SPIB/IRF8) to prime DC identity. The third factor (PRDM1 or IKZF2) directs the subtype-specific program in induced dendritic cells (iDCs).
August 29, 2025 at 4:15 PM
4/17 Screening in mouse embryonic fibroblasts revealed 2 key combos: PIP (PU.1, IRF4, PRDM1) activated Clec9a reporter & CD11b expression showing cDC2-like cell programming; SII (SPIB, IRF8, IKZF2) activated the Clec9a & hCD2 lymphoid reporters & BST2 expression- pDC-like cell
August 29, 2025 at 4:14 PM